Terity Diagnostics News Today

The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus.

/PRNewswire/ -- The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a...

/PRNewswire/ -- DxTerity Diagnostics today announced the commercial launch of their IFN-1 Test for patients with Systemic Lupus Erythematosus (SLE or lupus)....

/PRNewswire/ -- DxTerity Diagnostics today announced the opening of enrollment in ELEVATE (Empower Lupus Erythematous Patients Via Allowing RemoTe Evaluation),...

/PRNewswire/ -- In response to President Bidens urging that Americans go forward with their holiday plans, DxTerity Diagnostics announced today, it is...

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements Specialty Finance Portfolio Growth, Underlying Credit Performance Highlight Strong 2020 Closed Four Transactions During 2020, Deploying $35 Million Two Milestone Payments Received from Cara Therapeutics Related to the Development of Oral KORSUVA™ Fourth Quarter and Full-Year 2020 Financial Results Expected in March 2021 News provided by Share this article Share this article DALLAS, Feb. 16, 2021 /PRNewswire/ -- SWK Holdi...

Share this article Share this article LOS ANGELES, Dec. 18, 2020 /PRNewswire/ -- DxTerity Diagnostics is pleased to announce a strategic collaboration with Amazon to distribute its SARS-CoV-2 diagnostic tests to U.S. small businesses and customers at home. The self-administered, non-invasive saliva kits are FDA authorized for use by both individuals with and without symptoms of COVID-19. The kits are now available in individual and 10-pack kits on Amazon.  DxTeritys SARS-CoV-2 PCR-based test...